Emerge™ H7493918930400Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
All models of Emerge (54)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729806479), received between Mar 27, 2020 and Apr 22, 2024 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Material Rupture2
- Detachment of Device or Device Component1
- Difficult to Remove1
- Entrapment of Device1
Patient problems
- Cardiac Arrest1
- Device Embedded In Tissue or Plaque1
- Foreign Body In Patient1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 22, 2024Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. A 4.00MM X 30MM EMERGE BALLOON CATHETER WAS SELECTED FOR USE. HOWEVER, UPON TRACKING THE BALLOON THROUGH THE GUIDE CATHETER, THE BALLOON POPPED. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19155021 ↗InjuryOct 6, 2020Difficult to Remove; Material Rupture; Detachment of Device or Device Component; Difficult to Remove; Material Rupture; Detachment of Device or Device Component
IT WAS REPORTED THAT THE PATIENT EXPERIENCED CARDIAC ARREST AND WAS SENT FOR SURGERY. THE TARGET LESION WAS LOCATED IN THE CALCIFIED PROXIMAL LEFT ANTERIOR DESCENDING ARTERY (LAD). THE VESSEL WAS PREPPED USING A 1.25 ROTA PRO BURR. A 4.00MM X 30MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATION. HOWEVER, DURING INFLATION AT 12-14 ATMOSPHERES, THE BALLOON RUPTURED. DURING REMOVAL OF THE BALLOON, THE PHYSICIAN FELT SOME RESISTANCE. THE BALLOON PROXIMAL AND DISTAL MARKERS WERE STILL VISIBLE IN THE VESSEL AFTER REMOVING THE BALLOON CATHETER. PART OF THE BALLOON MATERIAL HAD BEEN TORN AND REMAINED IN THE VESSEL WITH THE MARKERS. THE PATIENT EXPERIENCED NO FLOW TO THE LAD. ANOTHER BALLOON WAS USED TO PLACE THE STENT WERE THE MARKERS WERE STUCK AND THE PHYSICIAN WAS ABLE TO RESTORE THE BLOOD FLOW ON THE VESSEL. HOWEVER, THE CIRCUMFLEX CORONARY ARTERY SHUT DOWN SO A ROUTINE PERCUTANEOUS CORONARY INTERVENTION TO THE VESSEL WAS PERFORMED TO RESTORE BLOOD FLOW. THE PATIENT STARTED TO CRASH SO CARDIOPULMUNARY RESUSCITATION WAS PERFORMED AND A NON-BSC DEVICE WAS INSERTED TO THE PATIENT. THE PATIENT UNDERWENT SURGERY TO THE GROIN FOR THE IMPELLA/ECMO GROIN COMPLICATIONS. NO FURTHER PATIENT COM
Patient problems: Cardiac Arrest; Device Embedded In Tissue or Plaque; Foreign Body In Patient
MAUDE report 10638018 ↗MalfunctionMar 27, 2020Entrapment of Device; Entrapment of Device
IT WAS REPORTED THAT CATHETER ENTRAPMENT OCCURRED. THE TARGET LESION WAS LOCATED IN A LEFT CORONARY ARTERY. AFTER A 300CM NON-BSC SUPPORT GUIDEWIRE CROSSED THE LESION, A 4.00MM X 30MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING WITHDRAWAL, THE BALLOON COULD NOT MOVE WITHOUT MOVING THE WIRE. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS NOR INJURIES WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9889520 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page